Insights into Medication-Induced Osteonecrosis of the Jaw Through the Application of Salivary Proteomics and Bioinformatics

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Nov 27

PMID 39596473

Authors

Vladimira Schwartzova

Galina Laputkova

Ivan Talian

Miroslav Marcin

Zuzana Schwartzova

Dominik Glaba

Affiliations

Soon will be listed here.

Abstract

Long-term treatment with bisphosphonates is accompanied by an increased risk of medication-related osteonecrosis of the jaw (MRONJ). Currently, no clinically useful biomarkers for the predictive diagnosis of MRONJ are available. To investigate the potential key proteins involved in the pathogenesis of MRONJ, a proteomic LC-MS/MS analysis of saliva was performed. Differentially expressed proteins (DEPs) were analyzed using BiNGO, ClueGO, cytoHubba, MCODE, KEGG, and ReactomeFI software packages using Cytoscape platforms. In total, 1545 DEPs were identified, including 43 up- and 11 down-regulated with a 1.5-fold cut-off value and . -value < 0.05. The analysis provided a panel of hub genes, including , , , , , , , , , , , , , , , and . The most prevalent terms in GO of the biological process were macromolecular complex remodeling, protein-lipid complex remodeling, and plasma lipoprotein particle remodeling. DEPs were mainly involved in signaling pathways associated with lipoproteins, the innate immune system, complement, and coagulation cascades. The current investigation advanced our knowledge of the molecular mechanisms underlying MRONJ. In particular, the research identified the principal salivary proteins that are implicated in the onset and progression of this condition.

References

Antonuzzo L, Lunghi A, Petreni P, Brugia M, Laffi A, Giommoni E . Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect. Curr Med Chem. 2017; 24(28):3068-3076. DOI: 10.2174/0929867324666170511113811. View

Tollefsen D . Heparin cofactor II modulates the response to vascular injury. Arterioscler Thromb Vasc Biol. 2006; 27(3):454-60. DOI: 10.1161/01.ATV.0000256471.22437.88. View

Querrer R, Ferrare N, Melo N, Stefani C, Reis P, Mesquita C . Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review. Support Care Cancer. 2020; 29(6):2811-2820. DOI: 10.1007/s00520-020-05855-6. View

Balachandran K, Ramli R, Karsani S, Abdul Rahman M . Identification of Potential Biomarkers and Small Molecule Drugs for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): An Integrated Bioinformatics Study Using Big Data. Int J Mol Sci. 2023; 24(10). PMC: 10218302. DOI: 10.3390/ijms24108635. View

Kim J, Yeon A, Parker S, Shahid M, Thiombane A, Cho E . Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental Pathophysiology. Int J Med Sci. 2021; 18(14):3261-3270. PMC: 8364444. DOI: 10.7150/ijms.61552. View

Lu X, Wu J, Qin Y, Liang J, Qian H, Song J . Identification of N-glycoproteins of hip cartilage in patients with osteonecrosis of femoral head using quantitative glycoproteomics. Int J Biol Macromol. 2021; 187:892-902. DOI: 10.1016/j.ijbiomac.2021.07.159. View

Tsukasaki M, Takayanagi H . Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat Rev Immunol. 2019; 19(10):626-642. DOI: 10.1038/s41577-019-0178-8. View

Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72(10):1938-56. DOI: 10.1016/j.joms.2014.04.031. View

Vaisar T, Tang C, Babenko I, Hutchins P, Wimberger J, Suffredini A . Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity. J Lipid Res. 2015; 56(8):1519-30. PMC: 4513993. DOI: 10.1194/jlr.M059089. View

10.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

11.

Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A . ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8):1091-3. PMC: 2666812. DOI: 10.1093/bioinformatics/btp101. View

12.

Bassan Marinho Maciel G, Maciel R, Linhares Ferrazzo K, Cademartori Danesi C . Etiopathogenesis of medication-related osteonecrosis of the jaws: a review. J Mol Med (Berl). 2024; 102(3):353-364. DOI: 10.1007/s00109-024-02425-9. View

13.

Tian L, Yu X . Lipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review). Mol Med Rep. 2015; 12(1):783-94. PMC: 4438959. DOI: 10.3892/mmr.2015.3472. View

14.

Schiodt M, Otto S, Fedele S, Bedogni A, Nicolatou-Galitis O, Guggenberger R . Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges. Oral Dis. 2019; 25(7):1815-1821. DOI: 10.1111/odi.13160. View

15.

Yang G, Singh S, McDonough C, Lamba J, Hamadeh I, Holliday L . Genome-wide Association Study Identified Chromosome 8 Locus Associated with Medication-Related Osteonecrosis of the Jaw. Clin Pharmacol Ther. 2021; 110(6):1558-1569. PMC: 8630710. DOI: 10.1002/cpt.2397. View

16.

Eklund K, Niemi K, Kovanen P . Immune functions of serum amyloid A. Crit Rev Immunol. 2012; 32(4):335-48. DOI: 10.1615/critrevimmunol.v32.i4.40. View

17.

Wang B, Wang H, Li Y, Song L . Lipid metabolism within the bone micro-environment is closely associated with bone metabolism in physiological and pathophysiological stages. Lipids Health Dis. 2022; 21(1):5. PMC: 8742318. DOI: 10.1186/s12944-021-01615-5. View

18.

Doncheva N, Morris J, Gorodkin J, Jensen L . Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J Proteome Res. 2018; 18(2):623-632. PMC: 6800166. DOI: 10.1021/acs.jproteome.8b00702. View

19.

Church F, Pratt C, Hoffman M . Leukocyte chemoattractant peptides from the serpin heparin cofactor II. J Biol Chem. 1991; 266(2):704-9. View

20.

Lee K, Kim S, Kim C, Min B, Kim G, Lim Y . Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study. J Transl Med. 2019; 17(1):381. PMC: 6868688. DOI: 10.1186/s12967-019-2129-3. View